University of Miami

 

 

University of Miami
F

Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab

By University of Miami FEATURING Flavia Nelson
By University of Miami FEATURING Flavia Nelson
0 views
December 28, 2023
Comments 1
Login to view comments. Click here to Login

Featured Video

07:37
UCB, Inc.

Taking the Next Steps with a Nasal Rescue Treatment

Feat. D. Burdette

Featured Video

02:58
UCB, Inc.

Empower Your Patients with an SAP

Feat. L. Hirsch
Neuromyelitis Optica Spectrum Disorders 2023
32:34
University of Miami

Everything a Neurologist Needs to Know About NMO & MOG

Feat. M. Levy
18:31
University of Miami

Optical Coherence Tomography (OCT) in Neuromyelitis Optica Spectrum …

Feat. H. Jiang
18:18
University of Miami

IL6 Receptor Inhibition in Treatment of NMOSD

Feat. K. Rammohan
33:02
University of Miami

NMO and MOG Case Presentations

Feat. H. Jiang, M. Levy, F. Nelson, K. Rammohan, M. Ortega
15:17
University of Miami

Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab

Feat. F. Nelson
23:01
University of Miami

Inebilizumab and Other Anti-B-Cell Depleting Therapies

Feat. K. Rammohan
20:07
University of Miami

Pregnancy in NMOSD

Feat. M. Ortega